NFE2L2 and Parkinson disease: For targeting PD therapies, the functions of MD and Sirtuins (SIRT1, 2, and 3), Nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway and the mitochondria- endoplasmic reticulum contact sites (MERCs) acts as potential targets [23].